BX Swiss TOP 30 CHF
1.310,43
PKT
-1,26
PKT
-0,10
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
Datum | Rating | Analyst | |
---|---|---|---|
18.05.05 | Roche Buy | Sarasin Research | |
17.05.05 | Kühne + Nagel International Market Perform | Vontobel | |
18.05.05 | Roche Overweight | JP Morgan | |
18.05.05 | Swisscom Underperform | Goldman Sachs | |
17.05.05 | UBS Outperform | Credit Suisse First Boston | |
17.05.05 | Swiss Life Underperformer | LB Rheinland-Pfalz | |
17.05.05 | Zurich Insurance Buy | Sarasin Research | |
13.05.05 | Roche Outperform | Goldman Sachs | |
17.05.05 | Swisscom Underweight | Lehman Brothers | |
17.05.05 | Lindt Neutral | Sarasin Research | |
17.05.05 | Swisscom Neutral | Credit Suisse First Boston | |
17.05.05 | Swiss Life Neutral | HypoVereinsbank | |
17.05.05 | Swisscom Neutral | Sarasin Research | |
11.05.05 | Holcim Halten | Helaba Trust | |
13.05.05 | Swiss Life Neutral | HypoVereinsbank | |
10.05.05 | Novartis Buy | Smith Barney Citigroup | |
10.05.05 | UBS Buy | Merrill Lynch | |
09.05.05 | Logitech In-Line | Goldman Sachs | |
09.05.05 | Swisscom Underweight | JP Morgan | |
10.05.05 | Holcim Verkaufen | Helaba Trust | |
10.05.05 | UBS Buy | Sarasin Research | |
10.05.05 | Swisscom Neutral | Sarasin Research | |
09.05.05 | Richemont Sector Perform | Vontobel | |
10.05.05 | UBS Buy | Sarasin Research | |
06.05.05 | UBS In-Line | Goldman Sachs | |
05.05.05 | Swisscom Underweight | Lehman Brothers | |
05.05.05 | UBS Kaufen | Hamburger Sparkasse | |
04.05.05 | Roche Buy | Helvea | |
03.05.05 | Holcim Overweight | JP Morgan | |
04.05.05 | UBS Buy | Helvea | |
03.05.05 | UBS Buy | Dresdner Kleinwort Wasserstein | |
04.05.05 | UBS Verkaufen | Helaba Trust | |
03.05.05 | UBS Strong Buy | SEB | |
03.05.05 | UBS Buy | Sarasin Research | |
09.05.05 | UBS Kaufen | NATIONAL-BANK | |
02.05.05 | Lonza Reduce | Sarasin Research | |
02.05.05 | Holcim Neutral | Sarasin Research | |
03.05.05 | Sika Neutral | Helvea | |
03.05.05 | Lonza Buy | Helvea | |
03.05.05 | Holcim Accumulate | Helvea |